China SXT Pharmaceuticals (SXTC) Long-Term Investments (2019 - 2022)
China SXT Pharmaceuticals (SXTC) posted quarterly Long-Term Investments of $1.6 million for Q3 2022, little changed year-over-year from $1.6 million in Q3 2021, and little changed quarter-over-quarter from $1.6 million in Q1 2022.
China SXT Pharmaceuticals (SXTC) Long-Term Investments (2019 - 2022) Analysis & Trends
China SXT Pharmaceuticals' Long-Term Investments history runs 4 years deep, the most recent figure standing at $1.6 million for Q3 2022.
- In Q3 2022, Long-Term Investments changed 0.0% year-over-year to $1.6 million; the TTM figure through Sep 2022 stood at $1.6 million (changed 0.0% YoY), while the FY2022 annual figure was $1.6 million, changed 0.0% from the prior year.
- Long-Term Investments for Q3 2022 stood at $1.6 million, roughly flat from $1.6 million in the prior quarter.
- The five-year high for Long-Term Investments was $3.5 million in Q3 2019, with the low at $1.6 million in Q1 2020.
- The 4-year median for Long-Term Investments is $1.6 million (2021), against an average of $1.9 million.
- The sharpest annual moves came in 2020 and 2021: Long-Term Investments plunged 54.03% in 2020, then grew 0.86% in 2021.
- China SXT Pharmaceuticals' Long-Term Investments stood at $3.5 million in 2019, then sank by 54.03% to $1.6 million in 2020, then fell by 1.68% to $1.6 million in 2021, then changed by 0.0% to $1.6 million in 2022.
- Business Quant data shows SXTC's Long-Term Investments at $1.6 million in Q3 2022, $1.6 million in Q1 2022, and $1.6 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 60.00 Mn |
| 10 | China SXT Pharmaceuticals | 31,562.64 | -28.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1.58 Mn |
| Mar 31, 2022 | 1.58 Mn |
| Sep 30, 2021 | 1.58 Mn |
| Mar 31, 2021 | 1.58 Mn |
| Sep 30, 2020 | 1.61 Mn |
| Mar 31, 2020 | 1.57 Mn |
| Sep 30, 2019 | 3.50 Mn |